InvestorsObserver is giving ENDRA Life Sciences Inc (NDRA) an Analyst Rating Rank of 74, meaning NDRA is ranked higher by analysts than 74% of stocks. The average price target for NDRA is $6 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating NDRA a Strong Buy today. Find out what this means to you and get the rest of the rankings on NDRA!